apology, by accident left out the essential bit of info, the phase 3 “MPACT” trial of gemcitabine and abraxane, 860 patients in total in that trial, pancreatic cancer metastatic, only one patient had a complete response.
apology, by accident left out the essential bit of info, the...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.001(1.00%) |
Mkt cap ! $35.10M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.6¢ | $182.0K | 1.835M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 142027 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.9¢ | 1123 | 1 |
View Market Depth
| Last trade - 14.55pm 14/11/2024 (20 minute delay) ? |
| ATX (ASX) Chart |